Indian Islands Challenge Supreme Court: End "Human Safaris"

Survival International Press Release July 24, 2012 Indian Islands Challenge Supreme Court Move To End Human Safaris A ruling by Indias Supreme Court which would have drastically curtailed the notorious human safaris in the Andaman Islands is being ignored by the islands authorities. Earlier this month Indias Supreme Court imposed a 5-kilometer buffer zone around the Jarawa Reserve, to help reduce the exploitation of the tribe by tourists. The ruling puts an end to tourist resorts near the Reserve, and closes other commercial attractions such as the Islands mud volcano and limestone caves Continue reading

FDA, EMA grant orphan drug designation to bluebird bio's gene therapy product for adrenoleukodystrophy

Published on June 19, 2012 at 9:32 AM bluebird bio, a leader in the development of innovative gene therapies for severe genetic disorders, announced today that both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have granted an orphan drug designation to its investigational gene therapy product for the treatment of adrenoleukodystrophy (ALD). Continue reading

bluebird bio Receives U.S. and European Orphan Drug Designation for Novel Gene Therapy to Treat Adrenoleukodystrophy

CAMBRIDGE, Mass.–(BUSINESS WIRE)– bluebird bio, a leader in the development of innovative gene therapies for severe genetic disorders, announced today that both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have granted an orphan drug designation to its investigational gene therapy product for the treatment of adrenoleukodystrophy (ALD). Continue reading